source
- Opinion: STAT+: China’s strict new supply chain regulations could create massive problems for Western biopharma companiesChina is now a peer competitor in drug innovation — and it intends to stay that way on its own terms, writes Dennis Kwok.STAT · 4mo ago↗ source
- Federal appeals court blocks mailing of abortion pill mifepristoneMifepristone, involved in most abortions in the U.S., can now be distributed only in person and at clinics.STAT · 4mo ago↗ source
- STAT+: Pharmalittle: We’re reading about obesity drugs and a compounding list, an AstraZeneca setback, and moreThe FDA proposed excluding the active ingredients in popular obesity and diabetes drugs from a list of substances that can be used for compounded versionsSTAT · 4mo ago